1 The effects of four specific inhibitors of 5-hydroxytryptamine (5-HT) uptake on morphine-, methadone-or pethidine-induced antinociception was studied in rats. Antinociception was assessed by means of hot plate (550C) reaction times. The effect of the compounds on the uptake of [3H]-5-HT into rat whole brain synaptosomes was also investigated. 
Introduction
There is considerable evidence to suggest that the antinociceptive effect of morphine is dependent upon intact central 5-hydroxytryptaminergic pathways (Messing & Lytle, 1977; Sewell & Spencer, 1977) . The elevation of brain content of 5-hydroxytryptamine (5-HT) either by the intracerebroventricular (i.c.v.) injection of 5-HT (Sparkes & Spencer, 1971) or by administering the 5-HT precursor 5-hydroxytryptophan (Contreras & Tamayo, 1967) potentiates morphineinduced antinociception in the rat. An alternative procedure for increasing 5-HT availability at the receptor is by inhibiting the uptake of the monoamine and it has been observed that pretreating rats with fluoxetine, a specific inhibitor of 5-HT uptake (Fuller, Perry & Molloy, 1975) , results in a potentiated antinociceptive response to morphine (Messing, Phebus, Fisher & Lytle, 1975; Sugrue & McIndewar, 1976; Larson & Takemori,. 1977) . In contrast to morphine, methadone-or pethidine-induced antinociception was unaltered by fluoxetine pretreatment (Sugrue & McIndewar, 1976) . The enhanced response to morphine following fluoxetine was attributed to an increased availability of 5-HT in the synaptic cleft as a consequence of 5-HT uptake inhibition. However, the possibility that the augmented response is due to factors other than blockade of 5-HT uptake warrants consideration. For 0007-1188/79/040677-05 $01.00 be altered and it is of interest to note that fluoxetine potentiates barbiturate sedation in rats by retarding hepatic metabolism (Fuller, Rathbun & Parli, 1976) . One of the objectives of this study was to determine if the ability to potentiate morphine-, but not methadone-or pethidine-induced antinociception is a property common to other specific inhibitors of 5-HT uptake. The other objective was to determine whether morphine potentiation could be correlated with inhibition of [3H]-5-HT uptake into a synaptosome-rich homogenate obtained from rat whole brain. The specific inhibitors of 5-HT uptake studied were Org 6582 (± )-8-chloro-11 -anti-amino-benzo-(b)-bicyclo-[3.3.1 ]-nona-3,6a (10a)-diene hydrochloride) (Sugrue, Goodlet & Mireylees, 1976; Mireylees, Goodlet & Sugrue, 1978) citalopram (Lu 10-171) (Hyttel, 1977) , femoxetine (FG 4963) (Buus Lassen, Squires, Christensen & Molander, 1975 ) and zimelidine (H 102/09) (Ross, Ogren & Renyi, 1976 of the hind paws. Reaction times were timed to the nearest second and each result was the mean of 6 to 8 observations. Statistical significance was determined by means of Student's t test (two tailed).
The uptake of [3H]-5-HT into a synaptosome-rich homogenate of whole brain was determined as described in detail elsewhere . Briefly, rats were killed and the brain quickly removed. The weighed brain was homogenized in 9 volumes of 0.32 M sucrose to yield a uniform suspension. Following centrifugation at 1000 g for 10 min at 4°C, the resultant supernatant was decanted and stirred to give a uniform suspension. A 0.1 ml aliquot of the suspension was preincubated for 10 min in 0.95 ml of a modified Krebs-bicarbonate buffer at 37°C under an atmosphere of 95% 02 and 5% CO2 in a Dubnoff metabolic shaker. [G-3H]-5-HT creatinine sulphate (14.0 Ci/mmol) was purchased from the Radiochemical Centre, Amersham. Fifty jl of [3WH-5-HT (final concentration of 2.6 x 10-8 M) was added and incubated for 5 min. Incubation was terminated by addition of 5 ml ice cold saline and by standing the beakers in ice for 10 min. The homogenate was separated from the medium by filtration under vacuum and after a further rinse with 5 ml ice cold which is defined as the dose of drug (mg/kg) required to inhibit uptake by 50% and was obtained from % uptake inhibition/log dose-response curves constructed by the method of least squares. Each log dose-response curve had at least three points and each point was the mean of at least four observations. The following drugs were dissolved in saline: citalopram hydrobromide, femoxetine hydrochloride, methadone hydrochloride, morphine hydrochloride, pethidine hydrochloride and zimelidine dihydrochloride. Org 6582 was dissolved in distilled water. All doses refer to the free base.
Results

Antinociceptive studies
Hot plate reaction times were unaltered 1 h after the intraperitoneal injection of Org 6582 (10 mg/kg), citalopram (10 mg/kg), zimelidine (10 mg/kg) or femoxetine (20 mg/kg) ( Table 1) .
The dose of analgesic selected was one which approx. doubled the reaction time of saline-treated rats. Morphine (2 mg/kg), methadone (1 mg/kg) and pethidine (10 mg/kg) all significantly increased hot plate reaction times 30 min after subcutaneous injection ( Table 2 ). The reaction time of morphine-treated rats was significantly increased following 30 min pretreatment with Org 6582, citalopram, zimelidine or femoxetine. In contrast, the prior administration of the 5-HT uptake inhibitors did not alter the reaction times of rats receiving methadone or pethidine (Table 4) .
Uptake studies
The effect of 1 h pretreatment with Org 6582, citalopram, femoxetine or zimelidine on the uptake of (Table 6 ).
Discussion
There is evidence to suggest that morphine-induced antinociception is dependent upon intact central Differs from control tP < 0.01; *differs from morphine *P < 0.05; **P < 0.001. Uptake inhibitors were injected intraperitoneally 24 or 48 h before morphine (2 mg/kg, s.c.) and control reaction times were 6.2 + 0.5 s. Remainder of legend as for Table 2 .
Differs from control tP < 0.001; differs from morphine *P < 0.05. ascending and descending 5-hydroxytryptaminergic nerve tracts (Yaksh, Plant & Ruddy, 1977; Deakin & Dostrovsky, 1978) . The results of this study confirm the importance of 5-HT in the antinociceptive action of morphine. In contrast, 5-HT may not play such a critical role in methadone-or pethidine-induced antinociception. Org 6582, citalopram, femoxetine and zimelidine are all potent inhibitors of 5-HT uptake, as assessed by the effect of 1 h pretreatment on the uptake of [3H]-5-HT into synaptosomes obtained from rat brain. The intraperitoneal doses required for a 50% inhibition of uptake ranged from 3.2 to 6.5 mg/kg.
Hot plate reaction times were unaltered following 1 h pretreatment with Org 6582, citalopram, zimelidine (all 10 mg/kg, i.p.) or femoxetine (20 mg/kg, i.p.). Following 30 min pretreatment with these doses, all four 5-HT uptake inhibitors potentiated the antinociceptive effect of morphine. One of the objectives of this study was to determine if morphine potentiation could be correlated with inhibition of 5-HT uptake. A precise correlation does not exist between the two phenomena. For example, femoxetine and zimelidine are essentially equipotent at blocking [3H]-5-HT uptake (ED50 values of 5.6 and 6.5 mg/kg respectively) yet zimelidine at a dose of 10 mg/kg potentiates the ability of morphine to increase hot plate reaction times whereas the same dose of femoxetine does not. This lack of total correlation may be due to the possibility that 5-HT uptake inhibitors vary quantitatively in their efficacy in blocking 5-HT uptake in different brain regions and that it is blockade of 5-HT uptake in a critical brain region which accounts for the observed potentiation of morphine-induced antinociception. An excellent temporal correlation exists between morphine potentiation and [3H]-5-HT uptake inhibition as indicated by the finding that of the four agents studied, only Org 6582 markedly blocked [3H]-5-HT uptake and potentiated antinociception after 24 h pretreatment. Following 48 h pretreatment Org 6582 was devoid of effect on both paradigms.
There is evidence to suggest that 5-HT may not be critically implicated in the antinociceptive effect of methadone or pethidine. For example, lesions of the nucleus raphe medianus attenuate the antinociceptive effect of morphine, but not that of methadone or pethidine (Samanin, Ghezzi, Mauron & Valzelli, 1973; Chance, Krynock & Rosecrans, 1978) . A further difference between morphine and pethidine is the finding that the antinociceptive effect of the former is attenuated whereas that of the latter is increased in rats depleted of brain 5-HT content after feeding on a tryptophan deficient diet (Phebus, 1978) . Moreover, of morphine, methadone and pethidine, only morphine increases rat brain 5-HT turnover following acute administration and this effect of morphine is blocked by pretreatment with the specific narcotic antagonist, naloxone (Goodlet & Sugrue, 1974; Sawa & Oka, 1976) . The inability of Org 6582, citalopram, femoxetine or zimelidine, at doses potentiating morphine, to alter the antinociceptive response to methadone or pethidine is in agreement with previous data for fluoxetine, another specific inhibitor of 5-HT uptake (Sugrue & Mclndewar, 1976) . In contrast to morphine, in vitro studies have revealed that methadone is a potent and pethidine a moderate inhibitor of 5-HT uptake into rabbit brain synaptosomes (Ciofalo, 1974) and human platelets (Ahtee & Saarnivaara, 1973) respectively. Sewell & Spencer (1977) have speculated that the inability of 5-HT uptake inhibitors to potentiate the antinociceptive effect of methadone or pethidine may be due to the fact that 5-HT uptake is partially inhibited by the two analgesics. However, in vivo findings argue against this hypothesis. For example, in vivo 5-HT uptake inhibition is often studied by determining the effect of drug pretreatment on the ability of p-chloroamphetamine to lower rat brain 5-HT levels. Org 6582, citalopram, femoxetine and zimelidine are all more potent than chlorimipramine at blocking the p-chloroamphetamine-induced fall in rat brain 5-HT content (Sugrue, Charlton, Mireylees & Mclndewar, 1978; unpublished observations). In contrast, the ability of p-chloroamphetamine to lower the concentration of 5-HT in rat brain was unaltered by methadone pretreatment (Fuller & Perry, 1976) . Other studies have also revealed that a very large dose of methadone (30 mg/kg) was needed for an approx. 50% inhibition of [3H]-5-HT uptake into rat hypothalamic synaptosomes 1 h after injection (Moffat & Jhamandas, 1976) . Finally, Carlsson & Lindqvist (1969) have shown that pethidine is a very weak inhibitor of the 4-methyl-otethyl-m-tyramine (H 75/12)-induced fall in the level of 5-HT in mouse brain.
In summary, four specific inhibitors of 5-HT uptake, Org 6582, citalopram, femoxetine and zimelidine, potentiate the antinociceptive effect of morphine, but not that of methadone or pethidine, in rats. There is an excellent temporal correlation between the ability of Org 6582 to potentiate morphineinduced antinociception and to block 5-HT uptake by rat whole brain. The findings of this study emphasize the importance of 5-HT in morphine-, but not methadone-or pethidine-induced antinociception.
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